Anastrozole EG 1 mg is a prescription medicine containing 1 mg of anastrozole per film-coated tablet. It belongs to the class of aromatase inhibitors and is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
By reducing estrogen production, anastrozole helps slow or prevent the growth of estrogen-dependent breast cancer cells. The medicine is manufactured according to European pharmaceutical quality standards and is intended for long-term therapy under medical supervision.
Anastrozole EG may be prescribed for:
After menopause, most estrogen is produced through the aromatase enzyme.
Anastrozole works by:
The usual adult dose is:
One 1 mg tablet once daily, preferably at the same time each day.
Treatment duration should always be determined by the treating physician.
Potential side effects include:
Regular clinical follow-up is recommended during therapy.
Do not use in patients with:
Store in the original package under the storage conditions recommended by the manufacturer. Keep out of reach of children.
It is used to treat hormone receptor-positive breast cancer in postmenopausal women.
Each tablet contains 1 mg of anastrozole.
The standard dosage is one tablet once daily, unless otherwise prescribed by a physician.
Yes. Anastrozole should only be used under the supervision of a qualified healthcare professional.
Yes. Bone health, treatment response, and routine clinical assessments should be monitored throughout therapy.
Each package contains 90 film-coated tablets.
Ask a question or inquire about delivery to your country

